News
Latest News, Announcements, and Press Releases
03Dec 14
Codexis Uses Its CodeEvolver(R) Protein Engineering Platform Technology to Develop an Enzyme Therapeutic Candidate for the Potential Treatment of Phenylketonuria (PKU) via Oral Administration
REDWOOD CITY, Calif., Dec. 3, 2014 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that it has developed a novel enzyme therapeutic product candidate for the…
read more25Nov 14
Codexis to Present at the LD Micro Main Event VII Conference on December 4
REDWOOD CITY, Calif., Nov. 25, 2014 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will provide a corporate update at the LD Micro Main Event…
read more07Nov 14
Merck and Codexis receive 2014 Thomas Edison Patent Award
Merck Research Laboratories, Merck & Co., and Codexis inventors Chris Savile, Emily Mundorff, Jeffrey C. Moore, Paul N. Devine, and Jacob M. Janey received a 2014 Thomas Edison Patent Award together for the groundbreaking Transaminase Biocatalysts invention, which was developed…
read more04Nov 14
Codexis Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2014
Conference Call Today at 4:30 pm ET REDWOOD CITY, Calif., Nov. 4, 2014 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced financial results for the third…
read more03Nov 14
Codexis Appoints Pam P. Cheng, Merck Global Executive, to Board of Directors
REDWOOD CITY, Calif., Nov. 3, 2014 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the appointment of Pam Cheng to its board of directors. Ms. Cheng…
read more21Oct 14
Codexis to Report Third Quarter 2014 Financial Results on November 4
REDWOOD CITY, Calif., Oct. 21, 2014 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will report third quarter financial results after the close of market…
read more22Sep 14
Codexis Appoints Biotechnology Industry Veteran, Kathleen Glaub, to Board of Directors
REDWOOD CITY, Calif., Sept. 22, 2014 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the appointment of Kathleen Sereda Glaub to its board of directors. Ms.…
read more19Sep 14
Gjalt Huisman Receives Industrial Biocatalysis Award
View Larger Image Gjalt Huisman of Codexis was awarded the “Biocat Award 2014 for Industrial Research” for his contributions in the field of industrial biocatalysis, at biocat2014, the 7th International Congress on Biocatalysis, held from August 31st to September…
read more06Aug 14
Codexis Reports Financial Results for the Second Quarter of 2014
Conference call today at 4:30 pm ET REDWOOD CITY, Calif., Aug. 6, 2014 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced its financial results for the…
read more31Jul 14
Codexis to Announce Second Quarter 2014 Financial Results on August 6, 2014
REDWOOD CITY, Calif., July 31, 2014 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will host a live conference call and audio webcast on Wednesday,…
read moreSince 2002, Codexis has created new technologies to unlock the power of proteins®. Put our unmatched protein engineering expertise to work for you.
Unlock the power of proteins® with Codexis
Learn More
Company
Industries